ArticleThe American journal of pathology2011

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

Paula Vainio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.